These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 26739469)
1. [Clinical significance of cysteinyl leukotriene receptor expression in primary hepatocellular carcinoma]. Sun X; Li J; Ren W; Fang J; Cheng Y; Ji Y Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):944-9. PubMed ID: 26739469 [TBL] [Abstract][Full Text] [Related]
2. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis. Liu B; Zhang J; Huang C; Liu H PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812 [TBL] [Abstract][Full Text] [Related]
3. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma. Zhu X; Qi G; Li C; Bei C; Tan C; Zhang Y; Shi W; Zeng W; Kong J; Fu Y; Tan S DNA Cell Biol; 2019 Feb; 38(2):193-197. PubMed ID: 30562063 [TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
6. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma. Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
8. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma]. Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257 [TBL] [Abstract][Full Text] [Related]
9. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]. Xie YM; Yan LN; Wei B; Guo MM; Tang CW Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
12. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients. Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]. Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386 [TBL] [Abstract][Full Text] [Related]
14. The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. Tian M; Yang X; Li Y; Guo S Med Sci Monit; 2020 Jun; 26():e923359. PubMed ID: 32573516 [TBL] [Abstract][Full Text] [Related]
15. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522 [TBL] [Abstract][Full Text] [Related]
16. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma. Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000 [TBL] [Abstract][Full Text] [Related]
17. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080 [TBL] [Abstract][Full Text] [Related]
18. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma. Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949 [TBL] [Abstract][Full Text] [Related]
19. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma. Guo X; Yang M; Gu H; Zhao J; Zou L Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]